Literature DB >> 17848122

Intra-individual variation in creatinine and cystatin C.

Niluka Bandaranayake1, Thelma Ankrah-Tetteh, Sethsiri Wijeratne, Ramasamyiyer Swaminathan.   

Abstract

BACKGROUND: Serum creatinine and cystatin C are measured in the assessment of glomerular filtration rate. Biological variation of an analyte is an important determinant of its usefulness. Intra-individual variation in serum creatinine and cystatin C in healthy subjects was determined in this study.
METHODS: Weekly blood samples were taken from 10 healthy subjects and analysed for creatinine (kinetic Jaffe method) and for cystatin C (by nephelometry).
RESULTS: Intra-individual variations for serum creatinine and cystatin C were 6.1% and 4.55%, respectively. Index of individuality values were similar for the analytes (0.35 for both).
CONCLUSION: Intra-individual variations for serum creatinine and cystatin C were similar in healthy subjects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17848122     DOI: 10.1515/CCLM.2007.256

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  8 in total

Review 1.  Measuring glomerular filtration rate in children; can cystatin C replace established methods? A review.

Authors:  Trine Borup Andersen; Anni Eskild-Jensen; Jørgen Frøkiaer; Jens Brøchner-Mortensen
Journal:  Pediatr Nephrol       Date:  2008-10-07       Impact factor: 3.714

2.  Estimating baseline kidney function in hospitalized patients with impaired kidney function.

Authors:  Edward D Siew; T Alp Ikizler; Michael E Matheny; Yaping Shi; Jonathan S Schildcrout; Ioana Danciu; Jamie P Dwyer; Manakan Srichai; Adriana M Hung; James P Smith; Josh F Peterson
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-15       Impact factor: 8.237

3.  Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis.

Authors:  Ayse L Mindikoglu; Antone R Opekun; William E Mitch; Laurence S Magder; Robert H Christenson; Thomas C Dowling; Matthew R Weir; Stephen L Seliger; Charles D Howell; Jean-Pierre Raufman; Abbas Rana; John A Goss; Saira A Khaderi; John M Vierling
Journal:  Dig Dis Sci       Date:  2018-02-01       Impact factor: 3.199

4.  Cystatin C--a paradigm of evidence based laboratory medicine.

Authors:  Janice S C Chew; Mohammed Saleem; Christopher M Florkowski; Peter M George
Journal:  Clin Biochem Rev       Date:  2008-05

5.  Changes in the concentrations of creatinine, cystatin C and NGAL in patients with acute paraquat self-poisoning.

Authors:  Darren M Roberts; Martin F Wilks; Michael S Roberts; Ramasamyiyer Swaminathan; Fahim Mohamed; Andrew H Dawson; Nick A Buckley
Journal:  Toxicol Lett       Date:  2011-02-01       Impact factor: 4.372

6.  Within-person reproducibility of proteoforms related to inflammation and renal dysfunction.

Authors:  Jie Gao; Adrian McCann; Johnny Laupsa-Borge; Ottar Nygård; Per Magne Ueland; Klaus Meyer
Journal:  Sci Rep       Date:  2022-05-06       Impact factor: 4.996

7.  The eGFR-C study: accuracy of glomerular filtration rate (GFR) estimation using creatinine and cystatin C and albuminuria for monitoring disease progression in patients with stage 3 chronic kidney disease--prospective longitudinal study in a multiethnic population.

Authors:  Edmund J Lamb; Elizabeth A Brettell; Paul Cockwell; Neil Dalton; Jon J Deeks; Kevin Harris; Tracy Higgins; Philip A Kalra; Kamlesh Khunti; Fiona Loud; Ryan S Ottridge; Claire C Sharpe; Alice J Sitch; Paul E Stevens; Andrew J Sutton; Maarten W Taal
Journal:  BMC Nephrol       Date:  2014-01-14       Impact factor: 2.388

8.  Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposure.

Authors:  Sophie Jose; Lisa Hamzah; Lucy J Campbell; Teresa Hill; Martin Fisher; Clifford Leen; Richard Gilson; John Walsh; Mark Nelson; Phillip Hay; Margaret Johnson; David Chadwick; Dorothea Nitsch; Rachael Jones; Caroline A Sabin; Frank A Post
Journal:  J Infect Dis       Date:  2014-02-28       Impact factor: 5.226

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.